GRCE GRACE THERAPEUTICS INC Management Changes 8-K Filing 2024 - Appointment of Robert J. DelAversano as principal financial officer and principal accounting officer Acasti Pharma appointed Robert J. DelAversano as principal financial officer and principal accounting officer, removing Brian Ford from the position of interim-Chief Financial Officer.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC